| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
|
Hepatology
|
2014
|
3.06
|
|
2
|
Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
J Natl Cancer Inst
|
2005
|
2.53
|
|
3
|
N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
2.01
|
|
4
|
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
|
Cancer Res
|
2007
|
1.82
|
|
5
|
Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
|
J Clin Endocrinol Metab
|
2006
|
1.71
|
|
6
|
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.67
|
|
7
|
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Endocr Relat Cancer
|
2008
|
1.65
|
|
8
|
Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg).
|
Heart
|
2010
|
1.56
|
|
9
|
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.
|
Arch Physiol Biochem
|
2009
|
1.55
|
|
10
|
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|
PLoS One
|
2008
|
1.50
|
|
11
|
Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.
|
Int J Cancer
|
2006
|
1.43
|
|
12
|
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
|
Breast Cancer Res
|
2012
|
1.37
|
|
13
|
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2010
|
1.28
|
|
14
|
The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.24
|
|
15
|
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.23
|
|
16
|
Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
|
Cancer Prev Res (Phila)
|
2011
|
1.23
|
|
17
|
Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
|
Int J Cancer
|
2007
|
1.21
|
|
18
|
Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Int J Cancer
|
2006
|
1.21
|
|
19
|
Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
|
Hum Mol Genet
|
2010
|
1.16
|
|
20
|
Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
|
Am J Epidemiol
|
2014
|
1.09
|
|
21
|
Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition.
|
Am J Epidemiol
|
2010
|
1.06
|
|
22
|
Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
|
BMC Cancer
|
2013
|
1.05
|
|
23
|
Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
|
Int J Cancer
|
2007
|
1.05
|
|
24
|
Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Endocr Relat Cancer
|
2007
|
1.02
|
|
25
|
A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Ann Hum Biol
|
2010
|
1.02
|
|
26
|
C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy).
|
Cancer Causes Control
|
2009
|
0.99
|
|
27
|
Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study.
|
Int J Cancer
|
2007
|
0.99
|
|
28
|
Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
|
Int J Cancer
|
2013
|
0.99
|
|
29
|
Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study.
|
Int J Cancer
|
2014
|
0.97
|
|
30
|
Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations.
|
Int J Cancer
|
2014
|
0.96
|
|
31
|
Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
|
Int J Cancer
|
2013
|
0.95
|
|
32
|
Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.
|
Int J Cancer
|
2013
|
0.94
|
|
33
|
C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Cancer Causes Control
|
2005
|
0.93
|
|
34
|
Prospective study on physical activity and risk of in situ breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.93
|
|
35
|
Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.
|
Am J Epidemiol
|
2008
|
0.92
|
|
36
|
Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.
|
Int J Cancer
|
2012
|
0.92
|
|
37
|
Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.92
|
|
38
|
Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition.
|
Int J Cancer
|
2012
|
0.90
|
|
39
|
Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study.
|
J Natl Cancer Inst
|
2014
|
0.90
|
|
40
|
Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.
|
Breast Cancer Res Treat
|
2014
|
0.90
|
|
41
|
Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition.
|
Cancer Causes Control
|
2011
|
0.89
|
|
42
|
Insulin-like growth factor-II methylation status in lymphocyte DNA and colon cancer risk in the Northern Sweden Health and Disease cohort.
|
Cancer Res
|
2009
|
0.89
|
|
43
|
Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Eur J Epidemiol
|
2014
|
0.89
|
|
44
|
Lobular breast cancer: incidence and genetic and non-genetic risk factors.
|
Breast Cancer Res
|
2015
|
0.88
|
|
45
|
The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.
|
Int J Cancer
|
2011
|
0.88
|
|
46
|
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
|
Eur J Cancer Prev
|
2005
|
0.87
|
|
47
|
Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.87
|
|
48
|
Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.87
|
|
49
|
Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort.
|
Int J Cancer
|
2012
|
0.87
|
|
50
|
Lifestyle, dietary factors, and antibody levels to oral bacteria in cancer-free participants of a European cohort study.
|
Cancer Causes Control
|
2013
|
0.86
|
|
51
|
Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis.
|
Am J Clin Nutr
|
2012
|
0.86
|
|
52
|
Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
|
Int J Cancer
|
2014
|
0.86
|
|
53
|
Fish consumption and mortality in the European Prospective Investigation into Cancer and Nutrition cohort.
|
Eur J Epidemiol
|
2014
|
0.85
|
|
54
|
Methylome analysis and epigenetic changes associated with menarcheal age.
|
PLoS One
|
2013
|
0.84
|
|
55
|
Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC.
|
PLoS One
|
2012
|
0.83
|
|
56
|
Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Cancer Causes Control
|
2013
|
0.82
|
|
57
|
Lifestyle factors and serum androgens among 636 middle aged men from seven countries in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Cancer Causes Control
|
2009
|
0.82
|
|
58
|
Dietary intakes and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).
|
Nutr Cancer
|
2013
|
0.82
|
|
59
|
Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
|
Int J Cancer
|
2014
|
0.82
|
|
60
|
Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
|
Int J Cancer
|
2013
|
0.81
|
|
61
|
North-south gradients in plasma concentrations of B-vitamins and other components of one-carbon metabolism in Western Europe: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
|
Br J Nutr
|
2012
|
0.81
|
|
62
|
Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008.
|
Am J Epidemiol
|
2014
|
0.80
|
|
63
|
Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.80
|
|
64
|
Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
|
Ann Epidemiol
|
2012
|
0.80
|
|
65
|
Fruit and vegetable intake and cause-specific mortality in the EPIC study.
|
Eur J Epidemiol
|
2014
|
0.80
|
|
66
|
Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort.
|
Breast Cancer Res
|
2015
|
0.79
|
|
67
|
Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
|
BMC Cancer
|
2009
|
0.78
|
|
68
|
Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
|
Am J Epidemiol
|
2014
|
0.78
|
|
69
|
Healthy Lifestyle and Risk of Cancer in the European Prospective Investigation Into Cancer and Nutrition Cohort Study.
|
Medicine (Baltimore)
|
2016
|
0.77
|
|
70
|
Life in urban areas and breast cancer risk in the French E3N cohort.
|
Eur J Epidemiol
|
2014
|
0.75
|